RIBAVIRIN-PEGYLATED INTERFERON ALFA HCV COMBINATION THERAPY.

• 1. 给首次接受抗病毒疗法的G慢性丙型肝炎感染患者施用包括利巴韦林和α干扰素的联合疗法 [P] . 中国专利： CN1230198C . 2005.12.07
• 2. 给首次接受抗病毒疗法的G慢性丙型肝炎感染患者施用包括利巴韦林和α干扰素的联合疗法 [P] . 中国专利： CN1309568A . 2001-08-22
• 3. Ribavirin-pegylated interferon alfa HCV combination therapy. [P] . ZA200302525B . 2004-07-21

  机译： 利巴韦林聚乙二醇干扰素αHCV联合治疗。

• 4. Ribavirin-pegylated interferon alfa induction HCV combination therapy [P] . 美国专利： US6824768B2 . 2004-11-30

  机译： 利巴韦林聚乙二醇干扰素α诱导HCV联合治疗

• 5. RIBAVIRIN-PEGYLATED INTERFERON ALFA HCV COMBINATION THERAPY [P] . 世界知识产权组织专利： WO0232414A3 . 2003-04-03

  机译： 利巴韦林-聚乙二醇干扰素α-丙肝病毒联合治疗

• 1. Predictability of Sustained Virological Response (SVR) in Patients with HCV/HIV Co-infection During Combination Therapy With Peginterferon Alfa-2A (40KD) (PEGASYS~R) Plus Ribavirin (COPEGUS~R) in the APRICOT Trial [C] . M. Rodriguez Torres, F.J. Torriani, E. Lissen International AIDS Conference . 2004
• 2. Inhibitory effects of acute and chronic ethanol consumption on interferon signaling in the liver: Implication in resistance to interferon therapy. [D] . Nguyen, Van-Anh Thi. 2001
• 3. Combination of low-dose ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy [O] . Perdita Wietzke-Braun, Volker Meier, Felix Braun, 2001
• 4. Combination of “low-dose” ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy [O] . Perdita Wietzke-Braun 2001

• 1. Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy [J] . Perdita Wietzke-Braun ,Volker Meier ,Felix Braun . 世界胃肠病学杂志：英文版 . 2001,第2期
• 2. Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin [J] . Chia-Yen Dai ,Wan-Long Chuang ,Wen-Yu Chang . 世界胃肠病学杂志：英文版 . 2005,第27期
• 3. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C [J] . Michael R Kraus ,Arne Sch(a¨)fer ,Herbert Csef . 世界胃肠病学杂志：英文版 . 2005,第12期
• 4. Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2:A project of the Kyushu University Liver Disease Study Group [J] . Norihiro Furusyo ,Masaki Katoh ,Yuichi Tanabe . 世界胃肠病学杂志：英文版 . 2006,第5期
• 5. Combination Therapy with Pegylated Interferon alpha-2b and Adefovir Dipivoxil in HBeAg-positive Chronic Hepatitis B versus Interferon Alone: A Prospective, Randomized Study [J] . Yu-hua LIU ,Tao WU ,Ning SUN . 华中科技大学学报（医学）（英德文版） . 2014,第004期
• 6. 聚乙二醇干扰素联合利巴韦林与α干扰素联合利巴韦林治疗慢性丙型肝炎疗效观察 [C] . . 第十七次全国中西医结合肝病学术会议 . 2008
• 7. 聚乙二醇化干扰素联合利巴韦林治疗肝移植术后丙型肝炎复发 [A] . 王平良 . 2013